https://www.optimumcomms.com/wp-content/uploads/2023/06/Calliditas_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-21 15:28:572023-06-21 15:28:57Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®
https://www.optimumcomms.com/wp-content/uploads/2023/06/Novo_Holdings23_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-21 15:25:322023-06-21 15:25:32Novo Holdings to acquire Ellab
https://www.optimumcomms.com/wp-content/uploads/2023/06/Versameb_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-21 08:55:462023-06-21 09:14:24Versameb Appoints Professor Roger Dmochowski as Chief Medical Officer
https://www.optimumcomms.com/wp-content/uploads/2023/06/Sequana_Medical_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-20 11:43:512023-06-21 09:13:16Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards
https://www.optimumcomms.com/wp-content/uploads/2023/06/SpliceBio_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-20 08:45:472023-06-21 09:12:26SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program
https://www.optimumcomms.com/wp-content/uploads/2023/06/adcendo_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-20 08:07:012023-06-21 09:11:51Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesenas Chief Medical Officer
https://www.optimumcomms.com/wp-content/uploads/2023/02/Nordic-Bioscinece_Logo_300x180px-2.png
180
300
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-06-15 11:06:172023-06-19 15:20:43Nordic Bioscience receives Letter of Support from the FDA for the PRO-C3 biomarker in tumor fibrosis
https://www.optimumcomms.com/wp-content/uploads/2023/02/Invizius_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-13 08:37:362023-06-13 09:21:34Invizius announces ‘Angry Blood’ Haemodialysis Study and recruits its 300th patient
https://www.optimumcomms.com/wp-content/uploads/2023/09/WiLD_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-13 08:31:432023-09-27 09:06:29Women in Life Science Denmark (WiLD) receives grant from The Lundbeck Foundation to support and advance its Female Leadership Mentoring Program
https://www.optimumcomms.com/wp-content/uploads/2023/02/FM_Logo_300px.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-12 07:46:182023-06-16 17:25:23Futura’s Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction Granted Marketing Authorisation by the US FDA for Over the Counter Sale
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-09 09:00:282023-06-15 11:25:24Vicore has carried out directed share issuances of in total 29,875,000 shares at a subscription price of SEK 16.75 per share, raising gross proceeds of SEK 500 million
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-07 07:09:112023-06-09 14:22:30Vicore further strengthens patent protection for C21
https://www.optimumcomms.com/wp-content/uploads/2023/02/Biocomposites_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-06 08:10:042023-06-08 17:03:03Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
https://www.optimumcomms.com/wp-content/uploads/2023/06/Synaffix_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-01 08:52:262023-06-16 17:26:06Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ionctura_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-01 08:27:052023-06-19 09:18:22iOnctura To Present Research At Leading Scientific Conferences In June 2023
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ariceum_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-01 08:12:072023-06-19 09:19:25Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd
https://www.optimumcomms.com/wp-content/uploads/2023/02/Zephyrus_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-30 11:30:462023-06-08 17:07:39Zephyrus Innovations appoints David Whitaker as Chief Technology Officer
https://www.optimumcomms.com/wp-content/uploads/2023/02/adcendo_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-30 08:05:472023-06-08 17:08:25Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-class ADC Pipeline
https://www.optimumcomms.com/wp-content/uploads/2023/06/Destiny_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-25 08:58:172023-06-08 17:07:13Destiny Pharma plc – Dr Debra Barker Appointed Interim CEO
https://www.optimumcomms.com/wp-content/uploads/2023/02/Verona_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-24 13:10:522023-06-08 17:08:51Verona Pharma to Present at Jefferies Healthcare ConferenceFor more information about Optimum Strategic Communications, please get in touch.
